UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 62

Sortiert nach

Differentiating Negligent Standards of Care in Diagnosis

Medical law review, 2022-02, Vol.30 (1), p.33-59

2022

Link zum Volltext

Verfügbarkeit prüfen

Guiding organisational decision-making about COVID-19 asymptomatic testing in workplaces: mixed-method study to inform an ethical framework

BMC public health, 2022-09, Vol.22 (1), p.1-1747, Article 1747

2022

Link zum Volltext

Verfügbarkeit prüfen

COVID-19 contact tracing apps: a stress test for privacy, the GDPR, and data protection regimes

Journal of law and the biosciences, 2020-01, Vol.7 (1), p.YY1-lsaa034

2020

Link zum Volltext

Verfügbarkeit prüfen

Allocating Medical Resources in the Time of Covid-19

The New England journal of medicine, 2020-05, Vol.382 (22), p.e79

2020

Link zum Volltext

Verfügbarkeit prüfen

Fair and Equitable Treatment and Judicial Patent Decisions

Journal of international economic law, 2016-03, Vol.19 (1), p.145-174

2016

Link zum Volltext

Verfügbarkeit prüfen

PATENT ENTITLEMENT CLAIMS: MARKEM OVERRULED

Cambridge law journal, 2008-07, Vol.67 (2), p.256-260

Liddell, Kathleen

2008

Link zum Volltext

Verfügbarkeit prüfen

Beyond Bristol and Alder Hey: the Future Regulation of Human Tissue

Medical law review, 2005-07, Vol.13 (2), p.170-223

2005

Link zum Volltext

Verfügbarkeit prüfen

Was the Myriad decision a 'surgical strike' on isolated DNA patents, or does it have wider impacts?

Nature biotechnology, 2018-12, Vol.36 (12), p.1146-1149

2018

Link zum Volltext

Verfügbarkeit prüfen

After Myriad, what makes a gene patent claim 'markedly different' from nature?

Nature biotechnology, 2017-09, Vol.35 (9), p.820-825

2017

Link zum Volltext

Verfügbarkeit prüfen

The sufficiency of disclosure of medical artificial intelligence patents

Nature biotechnology, 2024-06, Vol.42 (6), p.839-845

2024

Link zum Volltext

Verfügbarkeit prüfen

Mapping the European patent landscape for medical uses of known products

Nature biotechnology, 2021-11, Vol.39 (11), p.1336-1343

2021

Link zum Volltext

Verfügbarkeit prüfen

Patient data ownership: who owns your health?

Journal of law and the biosciences, 2021-07, Vol.8 (2), p.K1-lsab023

2021

Link zum Volltext

Verfügbarkeit prüfen

Myriad's impact on gene patents

Nature biotechnology, 2016-11, Vol.34 (11), p.1119-1123

2016

Link zum Volltext

Verfügbarkeit prüfen

How does emerging patent case law in the US and Europe affect precision medicine?

Nature biotechnology, 2019-10, Vol.37 (10), p.1118-1125

2019

Link zum Volltext

Verfügbarkeit prüfen

International transfers of health data between the EU and USA: a sector-specific approach for the USA to ensure an ‘adequate’ level of protection

Journal of law and the biosciences, 2020-01, Vol.7 (1), p.N1-lsaa055

2020

Link zum Volltext

Verfügbarkeit prüfen

Human embryo models: the importance of national policy and governance review

Current opinion in genetics & development, 2023-10, Vol.82, p.102103-102103, Article 102103

2023

Link zum Volltext

Verfügbarkeit prüfen

Standard contractual clauses for cross-border transfers of health data after Schrems II

Journal of law and the biosciences, 2021-01, Vol.8 (1), p.N1-lsab007

2021

Link zum Volltext

Verfügbarkeit prüfen

Mayo's impact on patent applications related to biotechnology, diagnostics and personalized medicine

Nature biotechnology, 2019-05, Vol.37 (5), p.513-518

2019

Link zum Volltext

Verfügbarkeit prüfen

Montgomery's legal and practical impact: A systematic review at 6 years

Journal of evaluation in clinical practice, 2022-08, Vol.28 (4), p.690-702

2022

Link zum Volltext

Verfügbarkeit prüfen

An empirical study of large, human biobanks: intellectual property policies and financial conditions for access

Journal of law and the biosciences, 2021-01, Vol.8 (1), p.U1-lsab018

2021

Link zum Volltext

Verfügbarkeit prüfen

Allocating Medical Resources in the Time of Covid-19

The New England journal of medicine, 2020-05, Vol.382 (22), p.e79-e79

2020

Link zum Volltext

Verfügbarkeit prüfen

Has the EU Incentive for Drug Repositioning Been Effective? An Empirical Analysis of the “+1” Regulatory Exclusivity

IIC - International Review of Intellectual Property and Competition Law, 2021-08, Vol.52 (7), p.825-851

2021

Link zum Volltext

Verfügbarkeit prüfen

One year after Vanda, are diagnostics patents transforming into methods of treatment to overcome Mayo-based rejections?

Nature biotechnology, 2020-03, Vol.38 (3), p.279-283

2020

Link zum Volltext

Verfügbarkeit prüfen

The Effects of Myriad and Mayo on Molecular-Test Development in the United States and Europe: Interviews from the Frontline

Vanderbilt journal of entertainment and technology law, 2020-06, Vol.22 (4), p.785

2020

Link zum Volltext

Verfügbarkeit prüfen

The frontiers of medical negligence and diagnosis: an interview-based analysis

Medical law review, 2023-11, Vol.31 (4), p.485-500

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(44)

Publikationsform

Sprache

Englisch
(61)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(32)
Life Sciences & Biomedicine
(31)
Humans
(17)
Social Sciences
(16)
Law
(15)
Government & Law
(12)
Intellectual Property
(11)
General & Internal Medicine
(9)
Legal Medicine
(8)
Medical Ethics
(8)
Medicine, General & Internal
(8)
Biotechnology & Applied Microbiology
(7)
Ethics
(7)
Medicine, Legal
(7)
Patent Law
(7)
Patients
(7)
Covid-19
(6)
Original
(6)
Clinical Trials
(5)
Health Aspects
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Differentiating Negligent Standards of Care in Diagnosis

Guiding organisational decision-making about COVID-19 asymptomatic testing in workplaces: mixed-method study to inform an ethical framework

COVID-19 contact tracing apps: a stress test for privacy, the GDPR, and data protection regimes

Allocating Medical Resources in the Time of Covid-19

Fair and Equitable Treatment and Judicial Patent Decisions

PATENT ENTITLEMENT CLAIMS: MARKEM OVERRULED

Beyond Bristol and Alder Hey: the Future Regulation of Human Tissue

Was the Myriad decision a 'surgical strike' on isolated DNA patents, or does it have wider impacts?

After Myriad, what makes a gene patent claim 'markedly different' from nature?

The sufficiency of disclosure of medical artificial intelligence patents

Mapping the European patent landscape for medical uses of known products

Patient data ownership: who owns your health?

Myriad's impact on gene patents

How does emerging patent case law in the US and Europe affect precision medicine?

International transfers of health data between the EU and USA: a sector-specific approach for the USA to ensure an ‘adequate’ level of protection

Human embryo models: the importance of national policy and governance review

Standard contractual clauses for cross-border transfers of health data after Schrems II

Mayo's impact on patent applications related to biotechnology, diagnostics and personalized medicine

Montgomery's legal and practical impact: A systematic review at 6 years

An empirical study of large, human biobanks: intellectual property policies and financial conditions for access

Allocating Medical Resources in the Time of Covid-19

Has the EU Incentive for Drug Repositioning Been Effective? An Empirical Analysis of the “+1” Regulatory Exclusivity

One year after Vanda, are diagnostics patents transforming into methods of treatment to overcome Mayo-based rejections?

The Effects of Myriad and Mayo on Molecular-Test Development in the United States and Europe: Interviews from the Frontline

The frontiers of medical negligence and diagnosis: an interview-based analysis

Suchergebnisse filtern